The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Manufacturing of recombinant therapeutic proteins in microbial systems
Abstract
Recombinant therapeutic proteins have gained enormous importance for clinical applications. The first recombinant products have been produced in E. coli more than 20 years ago. Although with the advent of antibody‐based therapeutics mammalian expression systems have experienced a major boost, microbial expression systems continue to be widely used in industry. Their intrinsic advantages, such as rapid growth, high yields and ease of manipulation, make them the premier choice for expression of non‐glycosylated peptides and proteins. Innovative product classes such as antibody fragments or alternative binding molecules will further expand the use of microbial systems. Even more, novel, engineered production hosts and integrated technology platforms hold enormous potential for future applications. This review summarizes current applications and trends for development, production and analytical characterization of recombinant therapeutic proteins in microbial systems.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Electrospray Ionization for Mass Spectrometry of Large Biomolecules
Fenn, J. B., Mann, M., Meng, C. K., Wong, S. F., & Whitehouse, C. M. (1989) · Science · doi:10.1126/science.2675315 · Cited by 7,634
Codon bias and heterologous protein expression
Gustafsson, C., Govindarajan, S., & Minshull, J. (2004) · Trends in Biotechnology · doi:10.1016/j.tibtech.2004.04.006 · Cited by 1,330
Overview of N- and O-linked oligosaccharide structures found in various yeast species
Gemmill, T. R., & Trimble, R. B. (1999) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/s0304-4165(98)00126-3 · Cited by 439
Optimization and scale up of industrial fermentation processes
Schmidt, F. R. (2005) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-005-0003-0 · Cited by 362
Levy, R., Weiss, R., Chen, G., Iverson, B. L., & Georgiou, G. (2001) · Protein Expression and Purification · doi:10.1006/prep.2001.1520 · Cited by 207
The Periplasmic Escherichia coli Peptidylprolyl cis,trans-Isomerase FkpA
Bothmann, H., & Plückthun, A. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m910233199 · Cited by 192
Optimizing scale-up fermentation processes
Thiry, M., & Cingolani, D. (2002) · Trends in Biotechnology · doi:10.1016/s0167-7799(02)01913-3 · Cited by 102
Two-dimensional fluorescence spectroscopy: A novel approach for controlling fed-batch cultivations
Hantelmann, K., Kollecker, M., Hüll, D., Hitzmann, B., & Scheper, T. (2006) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2005.07.016 · Cited by 80
Cited by
Recombinant protein expression in Escherichia coli: advances and challenges
Rosano, G. L., & Ceccarelli, E. A. (2014) · Frontiers in Microbiology · doi:10.3389/fmicb.2014.00172 · Cited by 2,556
Ronkainen, N. J., Halsall, H. B., & Heineman, W. R. (2010) · Chemical Society Reviews · doi:10.1039/b714449k · Cited by 1,945
Therapeutic antibodies: successes, limitations and hopes for the future
Chames, P., Van Regenmortel, M., Weiss, E., & Baty, D. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00190.x · Cited by 1,382
A Review of the Microbial Production of Bioactive Natural Products and Biologics
Pham, J. V., Yilma, M. A., Feliz, A., Majid, M. T., Maffetone, N., Walker, J. R., Kim, E., Cho, H. J., Reynolds, J. M., Song, M. C., et al. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.01404 · Cited by 565
Human cell lines for biopharmaceutical manufacturing: history, status, and future perspectives
Dumont, J., Euwart, D., Mei, B., Estes, S., & Kshirsagar, R. (2016) · Critical Reviews in Biotechnology · doi:10.3109/07388551.2015.1084266 · Cited by 483
Metadata
- Authors
- Graumann, K., & Premstaller, A.
- Venue
- Biotechnology Journal
- Publisher
- Wiley
- Published
- 2006-02
- Volume
- 1
- Issue
- 2
- Pages
- 164-186
- ISSN
- 1860-6768 (ISSN-L)
- 1860-7314
- OpenAlex
- W2067685428
- Cited by
- 208
- References
- 8
- FWCI
- 3.81
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Manufacturing of recombinant therapeutic proteins in microbial systems. https://app.cochat.ai/papers/10.1002/biot.200500051
- The paper
- Graumann, K., & Premstaller, A. (2006). Manufacturing of recombinant therapeutic proteins in microbial systems. Biotechnology Journal. https://doi.org/10.1002/biot.200500051
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.